免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA PMA

肥胖神经调节器

PMA编号:P130019 · 2019-02-15

决定日期2019-02-15
PMA 编号P130019
产品代码PIM
设备分类第3类
医疗专科U
咨询委员会GU 请注意,由于您只提供了“GU”这个词,我无法提供完整的翻译。如果您能提供完整的句子或段落,我将能够为您提供准确的翻译。

器械摘要

neuromodulator for obesity is the device name listed in this FDA 510(k) record. The listed applicant is Reshape Lifesciences, Inc.. It received FDA 510(k) clearance on 2019-02-15. The device is classified under product code PIM. It was reviewed by the GU advisory panel.

常见问题

What is the neuromodulator for obesity?

neuromodulator for obesity is a medical device that received FDA 510(k) clearance on 2019-02-15. The listed applicant is Reshape Lifesciences, Inc..

When did neuromodulator for obesity receive FDA 510(k) clearance?

The clearance date for neuromodulator for obesity can be found in the official FDA records.

Who is the listed applicant for neuromodulator for obesity?

The FDA 510(k) record lists Reshape Lifesciences, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for neuromodulator for obesity?

The FDA product code for neuromodulator for obesity is PIM.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑